Xilio Therapeutics Announces Pipeline and Business Updates and Fourth Quarter and Full Year 2025 Financial Results

Go back to Xilio Therapeutics Announces Pipeline and Business Updates and Fourth Quarter and Full Year 2025 Financial Results
(NASDAQ: XLO) Delayed: 9.18 +0.24 (2.68%)
Previous Close $8.94    52 Week High
Open $9.00    52 Week Low
Day High $9.30    P/E N/A 
Day Low $9.00    EPS
Volume 5,532